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Long non-coding RNAs (lncRNAs) are emerging as important regulatory molecules in devel-
opmental, physiological, and pathological processes. However, the precise mechanism and
functions of most of lncRNAs remain largely unknown. Recent advances in high-throughput
sequencing of immunoprecipitated RNAs after cross-linking (CLIP-Seq) provide powerful
ways to identify biologically relevant protein–lncRNA interactions. In this study, by analyzing
millions of RNA-binding protein (RBP) binding sites from 117 CLIP-Seq datasets generated
by 50 independent studies, we identified 22,735 RBP–lncRNA regulatory relationships.
We found that one single lncRNA will generally be bound and regulated by one or multi-
ple RBPs, the combination of which may coordinately regulate gene expression. We also
revealed the expression correlation of these interaction networks by mining expression
profiles of over 6000 normal and tumor samples from 14 cancer types. Our combined
analysis of CLIP-Seq data and genome-wide association studies data discovered hundreds
of disease-related single nucleotide polymorphisms resided in the RBP binding sites of
lncRNAs. Finally, we developed interactive web implementations to provide visualization,
analysis, and downloading of the aforementioned large-scale datasets. Our study repre-
sented an important step in identification and analysis of RBP–lncRNA interactions and
showed that these interactions may play crucial roles in cancer and genetic diseases.
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INTRODUCTION
Mammalian genomes encode thousands of long non-coding RNAs
(lncRNAs) (Wang and Chang, 2011; Guttman and Rinn, 2012).
lncRNAs play important roles in a variety of biological processes
that have been implicated in regulating tumorigenesis through
interaction with RNA-binding proteins (RBPs) (Konig et al., 2011;
Wang and Chang, 2011; Guttman and Rinn, 2012; Ulitsky and
Bartel, 2013). However, for the majority of lncRNAs, the mech-
anism underlying their interaction with RBPs remains unknown
(Konig et al., 2011; Wang and Chang, 2011; Guttman and Rinn,
2012; Ulitsky and Bartel, 2013).
The control and function of lncRNA are governed by the speci-
ficity of RBPs (Wang and Chang, 2011; Guttman and Rinn, 2012).
Increasing evidence suggests that many RBP–lncRNA interactions
play important roles in correct transcriptional regulation (Konig
et al., 2011; Wang and Chang, 2011; Guttman and Rinn, 2012;
Ulitsky and Bartel, 2013). One emerging theme that many lncR-
NAs regulate gene expression by directing chromatin modificators
to specific target regions (Ulitsky and Bartel, 2013). Significant
fractions (20% in human) of lincRNAs are interacted with PRC2
and other chromatin-modifying complexes (Khalil et al., 2009;
Guttman et al., 2011). The functional outcomes of some binding
events have been revealed. For example, HOTAIR, which is tran-
scribed from human HOX locus, guides repressor PRC2 to specific
mammalian loci to silence gene expression and to promote cancer
metastasis (Rinn et al., 2007; Wang et al., 2011). Besides, many
lncRNAs have been shown to interact with other types of RBPs,
including DNA methyltransferases (Schmitz et al., 2010; Di Ruscio
et al., 2013), transcription factors (Wang et al., 2014), and splicing
factors (Tripathi et al., 2010; Gong and Maquat, 2011; Yin et al.,
2012). However, deciphering the interactions between hundreds
of RBPs and thousands of lncRNAs remains a daunting challenge.
Genome-wide association studies (GWAS) have identified
thousands of common genetic variants related to specific traits
or disease phenotypes, and many of these variants (about 88%)
lie in non-coding regions, which could potentially influence pro-
cessing and expression of ncRNAs (Sethupathy and Collins, 2008;
Hindorff et al., 2009; Ryan et al., 2010; Cabili et al., 2011; Kumar
et al., 2013; Ning et al., 2014). For example, single nucleotide poly-
morphism (SNP) within miR-125a gene alters the processing of
pri-miRNA by DGCR8 and causes recurrent pregnancy loss in
a Han-Chinese population (Duan et al., 2007; Hu et al., 2011).
Another study found that a papillary thyroid carcinoma-associated
SNP, rs944289 affects the expression of lncRNA PTCSC3 by chang-
ing the binding activity of C/EBPα transcription factor (Cabili
et al., 2011; Jendrzejewski et al., 2012). Although the genetic vari-
ants in interaction sites of RBP–lncRNA may interfere lncRNA
functions and affected the susceptibility to human diseases, the
relationships between genetic variants and interaction sites were
yet unexplored.
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Recent advances in high-throughput sequencing of RNA iso-
lated by cross-linking immunoprecipitation (HITS-CLIP, CLIP-
Seq, PAR-CLIP, CLASH, iCLIP) have provided powerful ways to
identify RBP-associated RNAs and map such interactions in the
genome (Chi et al., 2009; Hafner et al., 2010; Konig et al., 2011; Hel-
wak et al., 2013; Fu, 2014; Fu and Ares, 2014). The application of
CLIP-Seq methods has reliably identified Argonaute (Ago) bind-
ing sites and miRNA-target interactome (Chi et al., 2009; Hafner
et al., 2010; Helwak et al., 2013). In fact, many more studies to date
have been focused on understanding the function of RBPs in RNA
metabolism (Konig et al., 2011; Fu, 2014), such as pre-mRNA splic-
ing (Fu and Ares, 2014). While an increasing number of RBPs have
been explored using CLIP technologies, binding peaks mapped to
non-protein-coding genes have been routinely discarded and not
further analyzed. However, this data will be a rich trove well worthy
of mining RBP–lncRNA relationships.
In this study, we performed a large-scale integration of pub-
lic RBP binding sites generated by high-throughput CLIP-Seq
technology and identified thousands of RBP–lncRNA interac-
tions. Furthermore, by combining GWAS and RNA-Seq data, we
explored clinically relevant RPB–lncRNA interactions that may
facilitate the translation of genetic studies of complex diseases
into therapeutics.
MATERIALS AND METHODS
INTEGRATION OF RBP BINDING SITES FROM PUBLISHED CLIP DATA
HITS-CLIP,PAR-CLIP,and iCLIP binding clusters/peaks data were
retrieved from the gene expression omnibus and sequence read
archive (SRA) (Barrett et al., 2013), the supplementary data of
original references or directly from authors upon request. All bind-
ing sites coordinates were converted to hg19 and mm10 assemblies
using the UCSC LiftOver Tool (Meyer et al., 2013).
RBP TARGET SITES SCANNING IN ANNOTATED lncRNA TRANSCRIPTS
Human gene annotations were acquired from GENCODE Version
17 (Harrow et al., 2012). Mouse gene annotations were extracted
from Ensembl Gene Release 72 (Hubbard et al., 2009) and LiftOver
to mm10 assembly. lncRNAs were further filtered to remove the
transcripts overlapping with protein-coding genes. The afore-
mentioned RBP CLIP clusters were used to intersect with the
coordinates of all annotated transcripts to find their RBP bind-
ing sites, which were fed to Circos (Krzywinski et al., 2009) for
visualization.
TCGA TUMOR EXPRESSION DATA AND EXPRESSION CORRELATION OF
RBPs AND lncRNAs
The Cancer Genome Atlas (TCGA) RNA-Seq expression datasets
(level 3, IlluminaHiSeq_RNASeqV2) for 14 cancer types and
gene annotation file (TCGA.hg19.June2011.gaf) were downloaded
from TCGA Data Portal (Cancer Genome Atlas Research Net-
work, 2008). Expression of 397 known lncRNAs can be measured
in TCGA level 3 RNA-Seq data. Expression correlation (Pearson
correlation coefficient) between lncRNAs and RBPs was estimated
using co-expression program (the program is available from the
authors upon request), which was written in C language and
ALGLIB library, and p-value was adjusted with the false discovery
rate (FDR) correction (Benjamini and Hochberg, 1995).
IDENTIFICATION OF DISEASE-RELATED SNPs IN RBP BINDING SITES
ASSOCIATED WITH lncRNAs
Disease/phenotype associated SNPs were curated from published
GWAS data provided by the NHGRI GWAS Catalog (Welter et al.,
2014), Johnson and O’Donnell (2009), dbGAP (Mailman et al.,
2007), and GAD (Becker et al., 2004). Additional SNPs in link-
age disequilibrium (LD) with reported disease-related loci were
selected with the criteria requiring an r2 value over 0.5 in at least
one of the four populations (CEU, CHB, JPT, and YRI) genotype
data of the HapMap project (release 28) (International HapMap 3
Consortium et al., 2010). For each SNP, rs ID were lifted to dbSNP
build 141 based on the “RsMergeArch.bcp” and “SNPHistory.bcp”
table from dbSNP, and genomic coordinates were lifted to the hg19
assembly using the UCSC LiftOver tool. All these disease-related
SNPs or LD SNPs were mapped to exons and splicing sites (2 nt
in the intron that is close to an exon) of the annotated lncRNA
transcripts and further examined whether they were located in
any RBP binding clusters.
DATA VISUALIZATIONS
RNA-binding protein–lncRNA interactions were deposited in our
starBase V2.0 (Li et al., 2014) under the “Protein–RNA” section1.
For each interaction, we provided links to our enhanced deepView
genome browser2, which was written using a GD graphics library
for PHP, to visualize RBP binding sites, lncRNAs, and other anno-
tation tracks in an integrated display style similar to that of UCSC
genome browser.
RESULTS
THE GENOME-WIDE BINDING MAP OF RNA-BINDING PROTEINS AND
THE ANNOTATION OF RBP–lncRNA INTERACTIONS
We curated 117 published CLIP-Seq datasets to profile the
genome-wide binding maps of 65 RBP. Unique binding sites of
distinct RBPs varied from thousands to millions, and the genomic
context distributions of binding sites for different RBPs distin-
guished from each other (Figure 1; Table S1 in Supplementary
Material). For example, PUM2, a translational repressor during
embryonic development and cell differentiation (Huang et al.,
2011), predominately bound to 3′UTR regions of protein genes,
while another translation inhibitor FMRP (Napoli et al., 2008)
tended to interact with CDS. The discrepancy in binding con-
text preferences for RBPs could root from different amounts of
available datasets, usages of various variants of CLIP-Seq, varying
sequencing depth, and/or genuine distinctions in the underlying
recognition mechanism of RBPs.
Despite that the majority of RBP binding sites were mapped
to protein-coding genes, on average 1.1% of RBP binding sites
lay within exons of human lncRNAs. In total, 21,073 and 1,662
RBP–lncRNA interactions were identified in human and mouse,
respectively (Table 1). It is noteworthy that most well-studied
lncRNAs interacted with chromatin modificators, acting as tethers
or scaffolds (Khalil et al., 2009; Kung et al., 2013). Thus, we consid-
ered the binding features of Ezh2, a subunit of PRC2 complexes,
by analyzing the CLIP-Seq data from mouse embryonic stem cells
1http://starbase.sysu.edu.cn/rbpLncRNA.php
2http://starbase.sysu.edu.cn/browser.php
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FIGURE 1 |The genomic context distributions of binding sites for 47 human RBPs. Binding sites are mapped to genomic features in the following priority
order: CDS, 3′UTR, 5′UTR, lncRNA, pseudogene, sncRNA, intron, intergenic.
Table 1 |The summary of CLIP-Seq datasets used in this study and the
resulting RBP–lncRNA interactions.
Species Experiments RBPs Cell
lines/
tissues
RBP binding
sites mapped
to lncRNAs
RBP–lncRNA
interactions
Human 90 47 13 84,356 21,073
Mouse 27 18 20 5,330 1,662
(Kaneko et al., 2013). Our results demonstrated that Ezh2 inter-
acted with 35 lncRNAs including many imprinted RNAs, such as
Tsix, Meg3, Rian, and Pvt1 (Figure 2), which was consistent with
the epigenetic features of PRC2 (Zhao et al., 2010).
EXPLORING COMBINATORIAL EFFECTS AMONG RBPs
For the 12,255 human lncRNAs, 56.8% were found bound to at
least 1 RBP. Surprisingly, 16 lncRNAs, including GAS5 and NEAT1,
harbored binding sites of over 30 RBPs (Figure 3; Table S2 in
Supplementary Material), indicating their diverse roles in biolog-
ical processes when accompanied with different RBPs. Since one
lncRNA could interact with multiple RBPs, it could be expected
that some RBP binding sites were overlapped with each other.
Therefore, we explored combinatorial effects among RBPs by
employing integrated CLIP-Seq datasets. For example, we utilized
PAR-CLIP data generated in HEK293 and intersect binding sites
of three RNA destabilizer HuR, Ago2, and MOV10. The results
showed that tens of lncRNAs, including cancer-related lncRNAs
TUG1, DLEU2, and GAS5, were bound by at least two of the
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FIGURE 2 |The genome-wide binding map of Ezh2 in mouse. The outer track is mouse chromosomes labeled with lncRNAs bound by Ezh2. The red tiles of
the inner track represent the genomic coordinates of corresponding binding sites.
three RBPs at identical binding sites (Figure 4). This phenomenon
suggested that the stabilities of these lncRNAs were likely under
joint control of these three RBPs, which could be explained by
their confirmed interplays in HEK293 (Chendrimada et al., 2007)
and Hela cells (Kim et al., 2009).
EXPRESSION ASSOCIATION OF RBP–lncRNA INTERACTIONS
To realize the roles of RBP–lncRNA interactions in cancer, we
preformed co-expression analysis between RBPs and lncRNAs
by virtue of 90 human CLIP-Seq datasets and expression
data from more than 6,000 tumor samples in 14 types of
cancer. Up to 583 pairs concerning 47 RBPs and 49 lncR-
NAs showed strong correlation at expression levels in at least
1 cancer type (Figure 5A). Marvelously, PUM2 and TUG1
involved with cell cycle regulation (Khalil et al., 2009; Huang
et al., 2011) showed significant positive expression correlation
(p< 0.05) in all 14 cancer types (Figure 5B). Two potential
PUM2 binding sites on TUG1 have the consensus recognition
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FIGURE 3 |The distribution of lncRNAs bound by different numbers of RBPs. Histograms showing counts of lncRNAs bound by over 10 RBPs are zoomed
in at the subpanel. SNHG1, GAS5, NEAT1, and SHNG16 are marked, which are bound by 42, 40, 39, and 39 RBPs, respectively.
motif UGURUAUA, which was highly conserved in mammals
(Figure 5C).
PREDICTING GWAS-ASSOCIATED RBP BINDING SITES IN lncRNAs
Although GWAS over the years have revealed a significant number
of genetic variants related to diseases or phenotypes, a consider-
able portion of these identified loci are not within protein-coding
genes and therefore not functionally explained to date (Hindorff
et al., 2009). Here, we tried to fill this gap by connecting RBP
binding sites in lncRNAs and potential disease-related SNPs.
Altogether, 87,677 unique disease-related SNPs were collected
from four public GWAS data source (Table S3 in Supplementary
Material, detailed in Section “Materials and Methods”). Consid-
ering that additional SNPs in LD with reported disease-related
loci may also map to RBP binding sites in lncRNAs, we perform
LD analysis to extracted SNPs that had high LD relationship with
disease-related SNPs using a threshold of r2 > 0.5 in at least one
population from the HapMap CEU, CHB, JPT, and YRI genotype
data, which yielded a total of 895,968 disease-related or LD SNPs.
We found that 2431 of these SNPs were mapped to the exons of
2089 transcripts of 1489 lncRNA genes, among which 162 SNPs
were also located in at least 1 binding sites of 29 RBPs (Table S4
in Supplementary Material). For example, three disease-related
SNPs, namely, rs16902485, rs10283090, and rs2720659, resided
in the exons of lncRNA PVT1. According to the GWAS annota-
tions of Johnson and O’Donnell (2009), the latter two of the three
SNPs were associated with “type II diabetes mellitus,” which was in
good accordance with the recent reports showing that PVT1 may
contribute to diabetic nephropathy (Hanson et al., 2007; Alvarez
and DiStefano, 2011; Alwohhaib et al., 2014). These SNPs were
also overlapped with binding sites of U2AF65, HuR, and eIF4AIII,
respectively (Figure 6), suggesting variants in these sites might
result in impaired binding of these RBPs to PVT1, which thereby
might lead to the development of corresponding diseases.
Next, we checked whether disease-related SNPs might be
located in the splicing sites of lncRNAs and affect the alterna-
tive splicing of lncRNAs. We defined a splicing site as the 2 nt
within an intron close to the exon–intron junction. As a result,
we found that only 24 SNPs lay within lncRNA splicing sites
(Table S4 in Supplementary Material), among which only 1 SNP,
rs17207481, was overlapped with binding sites of FUS and HuR.
These results suggested that SNPs exerted limited effects on dis-
ease occurrence through the mechanism of disturbing alternative
splicing of lncRNAs.
COMPARATIVE ANALYSIS OF RBP TARGETS USING THE deepView
GENOME BROWSER
To facilitate comparative analysis of the CLIP-Seq datasets and
exploration of RBP–lncRNA interactions, we developed the
improved deepView Genome Browser2 in starBase V2.0 (Li et al.,
2014). In the query page of the browser, users can input one
interested genomic region in the “search term” and select corre-
sponding genome assembly to gain an integrated view of various
genomic features. Information on binding sites of RBPs, predicted
miRNA-target sites overlapped with CLIP-Seq data, as well as gene
annotations from RefSeq and Ensembl were provided in toggleable
tracks. The image of the browser will be updated immediately
by clicking the “refresh tracks” button when users change track
options. Figure 7 illustrated the visualization of FUS–MEG3 inter-
actions with deepView. Users can click the“zoom in”or“zoom out”
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FIGURE 4 |The genome-wide binding map of HuR,Ago2, and MOV10 in
human. The outermost track represents ideograms of chr1, chr13, and chr22
in human genome. lncRNAs bound by these RBPs are labeled on the
periphery, and those bound by at least two of the three RBPs at identical
binding sites are colored red. The blue, green, and purple tracks indicate the
binding positions of HuR, Ago2, and MOV10, respectively.
button at the top to shrink or extend on the center of the anno-
tation tracks window by 1.5-, 3-, or 10-folds. Clicking the “View
region at UCSC” button will redirect users to the UCSC page
and exhibit the current region on the UCSC genome browser. To
explore RBP binding sites on a particular gene, users can type its
gene symbol in the position textbox and then click the “GO” but-
ton to update the display image to determine, which RBPs might
participate in regulating the gene. Our visualization method allows
a direct comparison of binding patterns of different RBPs, binding
preferences of one particular RBP in different cell lines and tissues,
and genomic contexts of RBP binding sites.
DISCUSSION
Although a few dozen lncRNAs have been characterized to
some extent and reported to function in important cellu-
lar processes, the functions of most annotated lncRNAs are
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FIGURE 5 | RBP–lncRNA interactions are supported by
co-expression analysis in 14 types of cancers. (A) Histograms show
RBP–lncRNA interactions with expression association (Pearson
correlation, p<0.05) in at least one cancer type. (B)The expression
levels of PUM2 and TUG1 are positively correlated (p<0.05) in all 14
cancers. (C)The PUM2 binding sites on TUG1 are inferred from
PAR-CLIP data, and the consensus recognition motif UGURUAUA are
conserved in mammals.
unknown (Guttman and Rinn, 2012; Ulitsky and Bartel, 2013).
Several bioinformatics resources and tools have made efforts to
functionally annotate lncRNAs (Da Sacco et al., 2012), such as
fRNAdb (Kin et al., 2007) and ncFANs (Liao et al., 2011). These
tools mainly inferred lncRNA function by their differential expres-
sion in distinct biological states or their co-expression patterns
with protein-coding genes, but little attention was paid to the rela-
tionship of lncRNAs and their bounded proteins. In this study, by
analyzing a large set of RBP binding sites derived from all available
CLIP-Seq experimental techniques (PAR-CLIP, HITS-CLIP, iCLIP,
CLASH), we have shown extensive and complex RBP–lncRNA
interaction networks (Figure 1).
Recent studies have revealed that many lncRNAs function
through specific interactions with RBPs, but whether these interac-
tions are direct and specific remains controversial. RBP–lncRNA
interactions identified by low stringent immunoprecipitation of
non-cross-linked RNA–protein complexes, such as RIP-Chip and
RIP-Seq, may contain indirect binding relationships (Konig et al.,
2011). In comparison to previously reported significant frac-
tions (10% in mouse) of PRC2-associated lncRNAs (Zhao et al.,
2008), we found that a relatively small fraction (~1%) of lncR-
NAs were bound by Ezh2 in mouse (Figure 2). Therefore, we
provide enhanced resolution to determine lncRNA functional
networks based on RBP–lncRNA interactions supported by high-
throughput CLIP-Seq data. More than 80,000 binding clusters
identified from 65 different RBPs represent a valuable resource
for resolving some obstacles that have arisen in efforts to under-
stand lncRNA action. Nevertheless, although CLIP-Seq is designed
to detect direct binding events of proteins and RNAs, the result-
ing data might still contain false positives and false negatives,
which may root from every cumbersome step of this technique.
To minimize the impact of such false discoveries, we filtered the
origin results by the reported FDR and provided evidences such
as number of CLIP reads and number of supporting experi-
ments, which may help users to gain RBP–lncRNA interactions
of high-confidence.
By cross analysis of binding maps for multiple RBPs, this study
offers a new resource to understanding joint control of target
lncRNA expression. While only 65 RBPs were analyzed, we found
that many of the RBPs bound to the same lncRNA (Figure 3).
This is consistent with the compelling idea that lncRNAs can serve
as scaffolds that assemble many relevant RBPs to regulate gene
expression (Wang and Chang, 2011; Ulitsky and Bartel, 2013).
At the same time, we also identified hundreds of identical binding
sites that bound by multiple different RBPs in lncRNAs (Figure 4),
probably reflecting competition among RBPs that binding on a
given lncRNA.
Our combined analysis of CLIP-Seq data and GWAS data
revealed hundreds of disease-related SNPs resided in the RBP
binding sites of lncRNAs (Table S4 in Supplementary Material).
Unlike the sporadic attempts on simply finding genetic vari-
ants associated with disease susceptibility within lncRNA genes
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FIGURE 6 |The GWAS-associated SNPs and binding sites of three
RBPs in the locus of PVT1. Gene annotations from UCSC, lncRNAs from
GENCODE, GWAS, and LD SNPs, binding sites of eIF4AIII/HuR/U2AF65
and LD plot from HapMap are shown accordingly. The SNP rs10283090
overlapped with binding sites of HuR and U2AF65 are zoomed in at the
bottom panel.
(Bochenek et al., 2013; Mirza et al., 2014), our approaches focused
on SNPs that might impact on the binding events between RBPs
and lncRNAs. Since most lncRNAs fulfill their roles through by
forming complex with their protein partners, our results provide
insights on the functions of lncRNAs from the perspective of RBP
binding malfunction in diseases, which in turn may contribute to
disease etiology.
Overall, our studies and the accompanying datasets demon-
strated that one single lncRNA will generally be bound and
regulated by one or multiple RBPs, the combination of which
may coordinately determine the final regulatory outcome.
We have also shown that an exhaustive and high-resolution
RBP–lncRNA interaction map will help to discover genetic vari-
ations that contribute to complex genetic diseases by affecting
post-transcriptional gene regulation.
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FIGURE 7 | An instance for displaying RBPs target sites in the
deepView Browser of starBaseV2.0. The predictive FUS binding sites
on MEG3 are visible in the RBP binding sites track. In this track, the
binding sites of other RBPs such as TDP-43 and PTB on MEG3 are also
showed, which facilitates comparative analysis of binding events of
multiple RBPs.
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